TMO
Thermo Fisher Scientific Inc.
- Total assets, 2025
- $110.3B
- YoY, 2025
- +13.4%
- 5-year CAGR
- +9.8%
- 10-year CAGR
- +10.5%
Total assets
Total assets by fiscal year
| Period | Total assets | YoY |
|---|---|---|
| 2025 | $110.3B | +13.4% |
| 2024 | $97.3B | −1.4% |
| 2023 | $98.7B | +1.6% |
| 2022 | $97.2B | +2.1% |
| 2021 | $95.1B | +37.8% |
| 2020 | $69.1B | +18.3% |
| 2019 | $58.4B | +3.8% |
| 2018 | $56.2B | −0.8% |
| 2017 | $56.7B | +23.4% |
| 2016 | $45.9B | +12.4% |
| 2015 | $40.8B | −4.7% |
| 2014 | $42.9B | +34.5% |
| 2013 | $31.9B | +16.1% |
| 2012 | $27.4B | +2.3% |
| 2011 | $26.8B | +25.7% |
| 2010 | $21.3B | −1.3% |
| 2009 | $21.6B | +2.5% |
| 2008 | $21.1B | — |